Managing infections in the immunocompromised patient.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 15768328.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Increasingly aggressive practices for treatment of patients with hematologic malignancies create challenges for successful management of infectious complications in immunocompromised patients. Infectious diseases practitioners face changing patterns of causative pathogens in their patients with febrile neutropenia, as well as evolving standards for empirical use of antimicrobial agents. The articles in this supplement issue of Clinical Infectious Diseases review these issues and their implications for current clinical practice.
Medical subject headings
- Anti-Bacterial Agents
- Immunocompromised Host
- Neoplasms
- Neutropenia
- Opportunistic Infections